Sofia Kenin 2023 Abierto Guadalajara Odds

As action in the Abierto Guadalajara nears its conclusion, a semifinal is coming up for Sofia Kenin versus Caroline Dolehide. Kenin has the fifth-best odds at +333 to win this tournament at Centro Panamericano de Tenis.

Find all the latest odds for the 2023 Abierto Guadalajara and place your bets with a new user bonus from BetMGM.

Sportsbook Promo Codes

Kenin at the 2023 Abierto Guadalajara

• Next Round: Semifinals
• Tournament Dates: September 15-23
• Venue: Centro Panamericano de Tenis
• Location: Guadalajara, Mexico
• Court Surface: Hard

Watch live sports without cable! Sign up today for a free trial to Fubo!

Kenin's Next Match

Kenin will play Dolehide in the semifinals on Friday, September 22 at 6:00 PM ET, after getting past Leylah Annie Fernandez in the last round 6-4, 6-7, 6-1.

Kenin currently has odds of -275 to win her next contest against Dolehide. Check out the latest odds for the entire field at BetMGM.

Want to bet on Kenin? Head to BetMGM using our link for a bonus bet special offer for new players!

Kenin Stats

• Kenin defeated Fernandez 6-4, 6-7, 6-1 on Thursday in the quarterfinals.
• The 24-year-old Kenin is 21-17 over the past 12 months and is still looking for her first tournament win.
• Kenin is 13-11 on hard courts over the past year.
• Through 38 matches over the past 12 months (across all court surfaces), Kenin has played 21.5 games per match. She won 52.8% of them.
• In her 24 matches on a hard surface over the past year, Kenin has averaged 21.9 games.
• Over the past 12 months, Kenin has been victorious in 35.2% of her return games and 71.0% of her service games.
• Kenin has won 35.1% of her return games on hard courts over the past 12 months. Meanwhile, she has claimed 71.2% of her service games during that timeframe.

Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER.